Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Analyses of Clinical Characteristics and Treatment Patterns of Breast Cancer Patients Initiating Palbociclib (Ibrance(Registered)) Treatment in Japan by Using MDV Database

NCT05153187 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05153187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05153187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Analyses of Clinical Characteristics and Treatment Patterns of Breast Cancer Patients Initiating Palbociclib (Ibrance(Registered)) Treatment in Japan by Using MDV Database
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 31, 2019
Completion date
June 30, 2021
Enrollment
1,170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer